Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 31;38(6):1564-1566.
doi: 10.1093/ndt/gfad010.

Serological response to Nuvaxovid (NVX-CoV2373) vaccine given as a fifth dose in non- and low-responder kidney transplant recipients

Alexandra Nowak  1   2 , Peter Hemmingsson  1   2 , Marie Evans  1   2 , Julia Wijkström  1   2
Affiliations

Serological response to Nuvaxovid (NVX-CoV2373) vaccine given as a fifth dose in non- and low-responder kidney transplant recipients

Alexandra Nowak et al. Nephrol Dial Transplant. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The results presented in this article have not been published previously in whole or part and it is not being considered for publication elsewhere. The authors have nothing to declare in relation to this work. M.E. reports payments for lectures (AstraZeneca, Astellas Pharma, Vifor Pharma, Baxter Healthcare, Fresenius Medical Care), travel grants (Baxter Healthcare) and participation in advisory board meetings (AstraZeneca, Astellas Pharma, Vifor Pharma).

Figures

Graphical Abstract
Graphical Abstract
Figure 1:
Figure 1:
Spike IgG (U/ml) before and after the fifth dose of vaccine against COVID-19. The fifth dose given was Nuvaxovid (NVX-CoV2373).
See this image and copyright information in PMC

References

    1. Sanders JSF, Bemelman FJ, Messchendorp ALet al. . The RECOVAC Immune-response Study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant. Transplantation 2022;106:821–34. - PMC - PubMed
    1. Galmiche S, Nguyen LBL, Tartour Eet al. . Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review. Clin Microbiol Infect 2022;28:163–77. - PMC - PubMed
    1. Alejo JL, Mitchell J, Chiang TPet al. . Antibody response to a fourth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series: erratum. Transplantation 2022;106:e177. - PubMed
    1. Thomson T, Prendecki M, Gleeson Set al. . Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipients. EClinicalMedicine 2022;53:101642. - PMC - PubMed
    1. Masset C, Benotmane I, Dantal Jet al. . A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients. Kidney Int 2022;101:825–6. - PMC - PubMed

Publication types